PLX
Navigation Links
PLX in Medical News
Protalix BioTherapeutics Appoints Professor Roger D. Kornberg to Board of Directors
... CARMIEL, Israel, Feb. 12 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), announced today that Professor Roger D. Kornberg, renowned Biochemist and laureate of the Nobel Prize in Chemistry, has been appointed to the Compa...Protalix BioTherapeutics Announces Resignation of Board Members
... CARMIEL, Israel, Dec. 5 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), announced today that two of its directors, Phillip Frost, M.D. and Jane H. Hsiao, Ph.D., have resigned from the Company's Board of Directors, effec...... CARMIEL, Israel, Dec. 3 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), noted today that prGCD, the Company's proprietary recombinant form of Glucocerebrosidase (GCD), which is used as an enzyme replacement therapy for ...
Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
... CARMIEL, Israel, Sept. 28 /PRNewswire-FirstCall/ -- The Russell Investment Group has advised Protalix Biotherapeutics (Amex: plx ) that there will be a float weight adjustment effective after the close of trading on September 28, 2007 in the following indexes: Russell 2000, Russ...PLX in Medical Technology
Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's Disease
NEW YORK--(BUSINESS WIRE)--Jun 14, 2007 - Pluristem Life Systems, Inc. (OTCBB:PLRS) (DAX:PJT), a bio-therapeutics Company dedicated to the commercialization of products for a variety of malignant, degenerative and auto-immune indications, announced today that Pluristem's PLacenta eXpanded (PLX) cel...... CARMIEL, Israel, Jan. 22 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), today announced that it has achieved proof of concept results in an animal study conducted as part of its Acetylcholinesterase (AChE) Program. The ...
Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
...ent treated in trial of prGCD treatment of Gaucher Disease CARMIEL, Israel, Aug. 27 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), today announced that it has treated the first patient in its phase III clinical trial of the Company's lead product candidate, prGCD, a proprietary...Pluristem to Present Two Scientific Posters at the International Society for Cellular Therapy
...ccessfully show how innovative our Placenta eXpanded (PLX) cells are. These plx cells are mesenchymal stem cells expanded in our proprietary 3D PluriX(TM) ...xogenous materials. Pluristem believes the resultant expanded cells, termed plx cells, are multipotent and able to differentiate into a variety of cell typ...PLX in Biological Technology
... CARMIEL, Israel, Jan. 14 /PRNewswire-FirstCall/ -- Protalix
BioTherapeutics, Inc. (Amex: plx ), announced today that it has signed a
lease agreement for the expansion of its manufacturing and research
facility. The expanded space, located in t...
Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
... CARMIEL, Israel, Nov. 29 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), today announced that its board of directors has set the close of business on December 24, 2007, as the record date for shareholders entitled to rec...Protalix BioTherapeutics to Present at CIBC World Markets 18th Annual Healthcare Conference
... CARMIEL, Israel, Nov. 2 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), today announced that Dr. David Aviezer, Ph.D., its President and Chief Executive Officer, will present at the CIBC World Markets 18th Annual Health...Protalix BioTherapeutics Announces Pricing of Public Offering of Common Stock
... CARMIEL, Israel, Oct. 24 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), announced today the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $5.00 per sha...Protalix BioTherapeutics Announces Public Offering of Common Stock
... CARMIEL, Israel, Oct. 7 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), today announced that it has commenced a proposed underwritten public offering of its common stock pursuant to a preliminary prospectus supplement t...Protalix BioTherapeutics to Present at UBS Global Life Sciences Conference
... CARMIEL, Israel, Sept. 19 /PRNewswire-FirstCall/ -- Protalix BioTherapeutics, Inc. (Amex: plx ), today announced that Dr. David Aviezer, its President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference at the G...EraGen cystic fibrosis test to be distributed worldwide through Bayer
...d, then quickly developed and deployed to detect contagions such as SARS. The company offers two patented platform technologies based on AEGIS, the plx and MultiCode RTx, which the company used recently to develop a test for SARS in the U.S., just seven days after the public release of the SARS geneti...Other TagsOther Contentsthuringiensisthuringiensisbacillusbacillusbacillusbacteriabacteriabacteriabacteriabacteriabacteriabacteriabacteriabacteriabackbackbackbackbackbackbackbackbackbackbackcrossbacteriophagebacteriophagebacteriophagebacteriophagebacteriophagesbacteriophagesbandbandbandbandbandbandbandband
RapamuneRanitidineQuinidineQuinineQuetiapineQuantiFERONQuaaludePyruvatePyridoxalPyridoxinePyridiumPyridostigminePyridiniumPyridinoline
(Date:11/27/2009)... Specialist manufacturers who use medical load ...llions of dollars by bringing in technology partne...numbers of pro-active medical manufacturers are ca...stage of their projects, ensuring that progress wi... or potentially outdated technology. , ...
(Date:11/26/2009)...Nov. 27 With cold and flu season u...od practices to control the spread of infections a...ot only to keep ourselves healthy, but to avoid tr...erty, RN, MS, CIC (certified in infection-control)...ational health at Hospital for Special Surgery (HS...
(Date:11/26/2009)..., the number of Americans living with diabetes wil...009 to 44.1 million in 2034. Over the same period,...rom $113 billion to $336 billion, even with no inc...sed at the University of Chicago report in the Dec...those with diabetes covered by Medicare will rise ...
(Date:11/26/2009)... or too heavy can lead to strains or worse , ... may be nothing wrong with stuffing your turkey fu...ame thing with your suitcase as you pack for holid...d in 2008 in U.S. hospital emergency rooms, doctor...or luggage-related injuries, such as muscle strain...
(Date:11/26/2009)... No more letters from the North Pole, Textsanta...ssages from Santa , North...ational efficiencies at the North Pole Santa Claus...n all over the globe informed of his Christmas pro...s research department have identified a large and ...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2[1] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells[1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use[0] Diabetes cases to double and costs to triple by 2034[3] Pack Right for the Holidays to Avoid the ER[1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes
(Date:11/24/2009)...rystallised a protein that may help gut bacteria b...ld be used by probiotic producers to identify stra...e. , "Probiotics need to interact with cells lini...y attach to surfaces in the gut they are more like...vity," says Dr Nathalie Juge from the Institute of...
(Date:11/24/2009)...tarctica has long held secrets of the earth,s hist...there has been very little information on the envi...e for millions of years. Now, a team of researcher... funded to the tune of $10 million dollars by the ... bottom of things literally. These scientists wil...
(Date:11/23/2009)... The community-associated strain of the deadly sup...to most common antibioticsposes a far greater heal...way into hospitals, according to a study in the De..., The new threat is easily picked up in fitness c...ncreased the overall burden of MRSA within hospita...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 1CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 2CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 3CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology 28ASTRO 29 Annual Meeting 5885 4Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center 5883 1Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center 5883 2Cancer Treatment Guidelines for Diverse Asian Economies Use Model Developed at Fred Hutchinson Cancer Research Center 5883 3Inappropriate Initial Antibiotic Treatment May Extend Stays for Patients with Healthcare Associated Skin Infections 5881 1Inappropriate Initial Antibiotic Treatment May Extend Stays for Patients with Healthcare Associated Skin Infections 5881 2Inappropriate Initial Antibiotic Treatment May Extend Stays for Patients with Healthcare Associated Skin Infections 5881 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |